CD38 and Miyoshi myopathy: MM cell lines RPMI-8226, MM.1S, XG-1 and KMS12-PE with an increasing dose of azacytidine (AZA) (1–3 μM) resulted in 1.2–2.4-fold increase in CD38 MFI in all the MM cell lines (Table 2).